Skip to content

Velocity Clinical Research (United States)

Velocity Clinical Research is an integrated clinical research site organization headquartered in Durham, NC, operating sites across the U.S. and Europe.

Last updated September 16, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Velocity Clinical Research is headquartered in Durham, NC and describes itself as the world's leading organization of fully integrated clinical research sites. With more than 70 sites and 200 investigators, it partners with pharmaceutical and biotechnology companies to research new drugs, medical devices, diagnostics, and combination products. It offers unified research site solutions for Phase 1-4 clinical trials across the U.S. and Europe, and also operates a technology hub in India. Velocity states it has supported more than 15,000 studies.

History

Velocity Clinical Research is headquartered in Durham, NC and describes itself as the world's leading organization of fully integrated clinical research sites. It states that it has conducted clinical trials since 1986 and has supported more than 15,000 studies. The company operates more than 70 sites with 200 investigators, providing unified research site solutions for Phase 1-4 clinical trials across the U.S. and Europe, and also operates a technology hub in India.

Products and positioning

The world's leading integrated site organization, offering world-class sites, reliable enrollment, and predictably high performance for clinical trials.

Recent events

  • Unconfirmed

    Velocity Clinical Research acquires VitaLink Research and National Research Institute[5]

    Reported:

    Velocity Clinical Research acquired VitaLink Research and the National Research Institute, gaining access to 11 clinical trial sites and expanding its presence into South Carolina and California.

  • Velocity Clinical Research announces agreement to be acquired by GHO Capital[6]

    Reported:

    Velocity Clinical Research announced an agreement to be acquired by GHO Capital from NaviMed Capital and other investors. The sale was expected to close in Q2 2021, subject to regulatory approval.

  • Velocity Clinical Research acquires two clinical research sites[7]

    Reported:

    Velocity Clinical Research announced the acquisitions of Downtown Women's Health Care in Colorado and Riverside Clinical Research in Florida, adding the two businesses to its North American site portfolio.

Sources7 sources

Cite this profile: Cite the canonical profile. /brand-wiki/velocity-clinical-research-united-states · Editorial policy · How profiles are compiled